Project Number T-PEP-18-580519C Agency/Funding Organization Alzheimer's Association|Tau Consortium Funding Year 2018 View Full Project Details for Therapeutic Approach for Targeting TAU Stress Granules Research Categorization Primary Disease / Condition Multiple Dementias CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) b. Tau Researcher and Organization Principal Investigator LARSEN, GLENN Principal Investigator First Name GLENN Principal Investigator Last Name LARSEN Awardee Organization Aquinnah Pharmaceuticals Inc Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement PA 2018: T-PEP RFA FY Overall Cost $750,000 Funding Organization Agency/Funding Organization Alzheimer's Association|Tau Consortium Program Official Murtishaw, Andrew asmurtishaw@alz.org
